Concord Securities Co., Ltd. (TPEX:6016)

Market Cap	7.86B
Revenue (ttm)	2.35B
Net Income (ttm)	53.68M
Shares Out	686.60M
EPS (ttm)	0.08
PE Ratio	150.01
Forward PE	n/a
Dividend	0.20 (1.79%)
Ex-Dividend Date	Aug 4, 2025

Volume	724,701
Average Volume	1,924,314
Open	11.45
Previous Close	11.45
Day's Range	11.35 - 11.50
52-Week Range	9.73 - 13.91
Beta	0.89
RSI	72.18
Earnings Date	Aug 29, 2025

About Theseus Pharmaceuticals

Concord Securities Co., Ltd., through its subsidiaries, provides brokerage and wealth management services in Taiwan. The company engages in trading securities proprietary and brokerage; underwriting; financing customers' acquisition and short sales; providing agency services for share affairs; assisting in futures trading; and other business. It also offers foreign and domestic futures proprietary, brokerage consulting services, and securities investment advisory services. In addition, the company provides asset management, investment, and busi...

• Industry: Capital Markets
• Sector: Financials
• Founded: 1990
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6016

Financial Performance

In 2024, Concord Securities's revenue was 3.60 billion, an increase of 12.27% compared to the previous year's 3.21 billion. Earnings were 1.09 billion, an increase of 9.28%.